Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases-Reference-Cited by-同舟云学术

Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases

Published:2019-09-03 Issue:11 Volume:352 Page:1900177
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch Pharm Chem Life Sci

Author:

Mathew Bijo¹^ORCID,Parambi Della G. T.²,Mathew Githa E.³,Uddin Md. Sahab⁴⁵,Inasu Sini T.¹,Kim Hoon⁶,Marathakam Akash⁷,Unnikrishnan Mazhuvancherry Kesavan⁷,Carradori Simone⁸

Affiliation:

1. Department of Pharmaceutical Chemistry Research Lab, Division of Drug Design and Medicinal Chemistry Ahalia School of Pharmacy Palakkad India

2. Department of Pharmaceutical Chemistry Jouf University Sakaka Saudi Arabia

3. Department of Pharmacology Grace College of Pharmacy Palakkad India

4. Department of Pharmacy Southeast University Dhaka Bangladesh

5. Pharmakon Neuroscience Research Network Dhaka Bangladesh

6. Department of Pharmacy and Research, Institute of Life Pharmaceutical Sciences Sunchon National University Suncheon Republic of Korea

7. Department of Pharmaceutical Chemistry National College of Pharmacy Calicut India

8. Department of Pharmacy “G. d'Annunzio” University of Chieti‐Pescara Chieti Italy

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.201900177

Reference126 articles.

1. The use of multi-target drugs in the treatment of neurodegenerative diseases

2. Multifunctional drugs with different CNS targets for neuropsychiatric disorders

3. Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases

4. Multimodal drugs and their future for Alzheimer's and Parkinson's disease

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INVESTIGATING MULTITARGET POTENTIAL OF MUCUNA PRURIENS AGAINST PARKINSON'S DISEASE: INSIGHTS FROM MOLECULAR DOCKING, MMGBSA, PHARMACOPHORE MODELLING, MD SIMULATIONS AND ADMET ANALYSIS;International Journal of Applied Pharmaceutics;2024-09-07

2. Novel Pyrrole Derivatives as Multi-Target Agents for the Treatment of Alzheimer’s Disease: Microwave-Assisted Synthesis, In Silico Studies and Biological Evaluation;Pharmaceuticals;2024-09-04

3. Exploring molecular interactions and ADMET profiles of novel MAO-B inhibitors: toward effective therapeutic strategies for neurodegenerative disorders;Future Journal of Pharmaceutical Sciences;2024-09-02

4. Investigation of dual AChE/MAO inhibitory activities of new morpholine and piperazine structured compounds;European Journal of Life Sciences;2024-08-30

5. An update on novel and emerging therapeutic targets in Parkinson’s disease;Metabolic Brain Disease;2024-07-27